Ignite Creation Date:
2024-05-06 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05291052
Status:
UNKNOWN
Last Update Posted:
2022-03-22
First Post:
2022-03-14
Brief Title:
Tisleizumab Combined With Lenvatinib and XELOX Regimen Oxaliplatin Combined With Capecitabine in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Biliary Tract Tumor |
Keywords: